Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer.
In carcinogenesis, the "field defect" is recognized clinically because of the high propensity of survivors of certain cancers to develop other malignancies of the same tissue type, often in a nearby location. Such field defects have been indicated in colon cancer. The molecular abnormalities that are responsible for a field defect in the colon should be detectable at high frequency in the histologically normal tissue surrounding a colonic adenocarcinoma or surrounding an adenoma with advanced neoplasia (well on the way to a colon cancer), but at low frequency in the colonic mucosa from patients without colonic neoplasia. Using immunohistochemistry, entire crypts within 10 cm on each side of colonic adenocarcinomas or advanced colonic neoplasias were found to be frequently reduced or absent in expression for two DNA repair proteins, Pms2 and/or ERCC1. Pms2 is a dual role protein, active in DNA mismatch repair as well as needed in apoptosis of cells with excess DNA damage. ERCC1 is active in DNA nucleotide excision repair. The reduced or absent expression of both ERCC1 and Pms2 would create cells with both increased ability to survive (apoptosis resistance) and increased level of mutability. The reduced or absent expression of both ERCC1 and Pms2 is likely an early step in progression to colon cancer. DNA repair gene Ku86 (active in DNA non-homologous end joining) and Cytochrome c Oxidase Subunit I (involved in apoptosis) had each been reported to be decreased in expression in mucosal areas close to colon cancers. However, immunohistochemical evaluation of their levels of expression showed only low to modest frequencies of crypts to be deficient in their expression in a field defect surrounding colon cancer or surrounding advanced colonic neoplasia. We show, here, our method of evaluation of crypts for expression of ERCC1, Pms2, Ku86 and CcOI. We show that frequency of entire crypts deficient for Pms2 and ERCC1 is often as great as 70% to 95% in 20 cm long areas surrounding a colonic neoplasia, while frequency of crypts deficient in Ku86 has a median value of 2% and frequency of crypts deficient in CcOI has a median value of 16% in these areas. The entire colon is 150 cm long (about 5 feet) and has about 10 million crypts in its mucosal layer. The defect in Pms2 and ERCC1 surrounding a colon cancer thus may include 1 million crypts. It is from a defective crypt that colon cancer arises.
Nguyen
Huy
H
Department of Cell Biology and Anatomy, College of Medicine, University of Arizona, Tucson, USA.
Loustaunau
Cristy
C
Facista
Alexander
A
Ramsey
Lois
L
Hassounah
Nadia
N
Taylor
Hilary
H
Krouse
Robert
R
Payne
Claire M
CM
Tsikitis
V Liana
VL
Goldschmid
Steve
S
Banerjee
Bhaskar
B
Perini
Rafael F
RF
Bernstein
Carol
C
D000251:Adenosine Triphosphatases / Q000172:deficiency*; D034961:Antigens, Nuclear; D003110:Colonic Neoplasms / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology; D003113:Colonoscopy; D030401:Cytochrome-c Oxidase Deficiency / Q000378:metabolism*; D045643:DNA Repair Enzymes / Q000172:deficiency*; D004268:DNA-Binding Proteins / Q000172:deficiency*; D018450:Disease Progression; D003576:Electron Transport Complex IV / Q000378:metabolism; D004720:Endonucleases / Q000172:deficiency*; D006801:Humans; D000072200:Ku Autoantigen; D000070976:Mismatch Repair Endonuclease PMS2; D011230:Precancerous Conditions / Q000378:metabolism* / Q000473:pathology
D034961:Antigens, Nuclear; D004268:DNA-Binding Proteins; D003576:Electron Transport Complex IV; C071447:ERCC1 protein, human; D004720:Endonucleases; D000251:Adenosine Triphosphatases; C094934:PMS2 protein, human; D000070976:Mismatch Repair Endonuclease PMS2; C000606509:Xrcc6 protein, human; D000072200:Ku Autoantigen; D045643:DNA Repair Enzymes